Skip to content

IVEMAR

Active
Private limited companyfounded 2004active for 22 yearsAvenue Léon Champagne 5, 1480 Tubize, BelgiumKBO/BCE: BE 0867.168.023
Summary

The computed 12-month bankruptcy probability of IVEMAR is 9.6% (elevated). The 2025 annual accounts show negative equity (-€4.8m) and a net result of -€3.2m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 886 sector peers (NACE 52, financial year 2025). The company has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals.

Directors

Directors
3 directors, 2 in day-to-day management, no change since 2026

Board 3

Hyacinthe-Eric Chaudoir
Director · since 14-11-2024
Current
WALDEN GROUP INTERNATIONAL HOLDING B.V.
Director · since 18-03-2025 · Legal entity · permanent representative: Laure Brenas
Current
S CONSULT
Director (not named in the articles) · Private limited company · permanent representative: SMETS Yves
Current

Day-to-day management 2

Michiel Heller
Gedelegeerde tot het dagelijks bestuur · since 25-07-2024
Current
Nick Sims
Gedelegeerde tot het dagelijks bestuur · since 25-07-2024
Current

Permanent representatives 2

Laure Brenas
Permanent representative · since 18-03-2025 · for WALDEN GROUP INTERNATIONAL HOLDING B.V.
Current
SMETS Yves
Permanent representative · for S CONSULT
Current

Statutory auditor 1

Forvis Mazars Réviseurs d’Entreprises
Statutory auditor · since 02-04-2024 · permanent representative: Koen POTTERS
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →

Mandate history

11 people since 2013, 6 in office
Show
  • Board
  • Day-to-day management
  • Statutory auditor
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
S CONSULT
  • Manager, from 01-01-2013 to 31-08-2022
  • Director (not named in the articles), from 31-08-2022 to 20-10-2023
  • Director (not named in the articles), from 31-08-2022 to date
Hyacinthe-Eric Chaudoir
  • Director, from 14-11-2024 to date
WALDEN GROUP INTERNATIONAL HOLDING B.V.
  • Director, from 18-03-2025 to date
Michiel Heller
  • Gedelegeerde tot het dagelijks bestuur, from 25-07-2024 to date
Nick Sims
  • Gedelegeerde tot het dagelijks bestuur, from 25-07-2024 to date
Forvis Mazars Réviseurs d’Entreprises
  • Statutory auditor, from 02-04-2024 to date
Nick (Nicholas) Sims
  • Daily management delegate, until 25-03-2026
Benoit Latteur
  • Director, from 14-11-2024 to 10-12-2025
TRANSPHARMA INTERNATIONAL HOLDING B.V.
  • Director, from 20-10-2023 to 03-04-2025
David Evans
  • Director, from 20-10-2023 to 14-11-2024
SMETS Yves
  • Manager, until 01-01-2013
See the board, name and registered office on a given date →

Owners and capital

Owners

2 owners

Chain of control

  1. Walden Group International Holding BVNL consolidates
  2. Walden Group International HoldingNL 100%
  3. IVEMAR

Highest known parent: Walden Group International Holding BV (Netherlands). The sources do not say who stands above it.

Owners 2

According to the 2025 annual accounts of IVEMAR and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.

Capital and shareholders

Shareholders according to the deeds
After the capital increase act of 15-04-2014 ↗
  • SMETS Yves €41,310
  • PLETINCX Vera €4,590

The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 26-11-2025 Capital stated in 4 acts · 100 shares
  2. 15-04-2014 Capital increase of €45,900 · to €64,500 · in cash